Article Versions Notes

Mohammadzadeh A, Lakatos PP, Balogh M, Zádor F, Karádi DÁ, Zádori ZS, Király K, Galambos AR, Barsi S, Riba P, et al. Pharmacological Evidence on Augmented Antiallodynia Following Systemic Co-Treatment with GlyT-1 and GlyT-2 Inhibitors in Rat Neuropathic Pain Model. International Journal of Molecular Sciences. 2021; 22(5):2479. https://doi.org/10.3390/ijms22052479

Mohammadzadeh, Amir, Péter P. Lakatos, Mihály Balogh, Ferenc Zádor, Dávid Árpád Karádi, Zoltán S. Zádori, Kornél Király, Anna Rita Galambos, Szilvia Barsi, Pál Riba, and et al. 2021. "Pharmacological Evidence on Augmented Antiallodynia Following Systemic Co-Treatment with GlyT-1 and GlyT-2 Inhibitors in Rat Neuropathic Pain Model" International Journal of Molecular Sciences 22, no. 5: 2479. https://doi.org/10.3390/ijms22052479

Mohammadzadeh, A., Lakatos, P. P., Balogh, M., Zádor, F., Karádi, D. Á., Zádori, Z. S., Király, K., Galambos, A. R., Barsi, S., Riba, P., Benyhe, S., Köles, L., Tábi, T., Szökő, É., Harsing, L. G., Jr., & Al-Khrasani, M. (2021). Pharmacological Evidence on Augmented Antiallodynia Following Systemic Co-Treatment with GlyT-1 and GlyT-2 Inhibitors in Rat Neuropathic Pain Model. International Journal of Molecular Sciences, 22(5), 2479. https://doi.org/10.3390/ijms22052479